|
NOTE 15—REVENUES
| |
|
2017 |
|
|
2018 |
|
| |
|
NIS in
thousands |
|
| Revenues from the sales of goods |
|
|
1,668 |
|
|
|
2,657 |
|
| Revenues from the rendering of services |
|
|
- |
|
|
|
682 |
|
| Revenues from licensing agreement (see Note 2N) |
|
|
- |
|
|
|
14,695 |
|
| |
|
|
1,668 |
|
|
|
18,034 |
|
|
B. |
Revenues by geographical area (based on the location of customers): |
| |
|
2017 |
|
|
2018 |
|
| |
|
NIS in
thousands |
|
| United states and Canada |
|
|
802 |
|
|
|
17,511 |
|
| Europe |
|
|
866 |
|
|
|
523 |
|
| |
|
|
1,668 |
|
|
|
18,034 |
|
Set forth below is a breakdown of the Company’s revenue by major customers (major customer –revenues from these customers constitute at least 10% of total revenues in a certain year):
| |
|
2017 |
|
|
2018 |
|
| |
|
NIS in
thousands |
|
| Customer A |
|
|
688 |
|
|
|
15,375 |
|
| |
|
|
|
|
|
|
|
|
| Customer B |
|
|
521 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Customer C |
|
|
295 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| Customer D |
|
|
- |
|
|
|
1,816 |
|
| D. |
The changes in contract liability relating to goods that were not yet delivered are as follows: |
| |
|
2018 |
|
| |
|
NIS in
thousands |
|
| Balance as of January 1, 2018 |
|
|
- |
|
| Contract liability recognized due to LB agreement |
|
|
7,346 |
|
| Revenue recognized during the period |
|
|
(37 |
) |
| Balance as of December 31, 2018(1)
|
|
|
7,309 |
|
| Contract liability presented in current liabilities |
|
|
3,636 |
|
| Contract liability presented in non-current liabilities(2)
|
|
|
3,673 |
|
|
(1) |
Represents the unfulfilled performance obligation related to First BioInk. |
|
(2) |
As of December 31, 2018, non-current contract liabilities are estimated to be recognized in 2020. |
|